HEALTHPEAK PROPERTIES INC (DOC) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:DOC - US42250P1030 - REIT
16.745 USD
+0.13 (+0.75%)
We assign a fundamental rating of 3 out of 10 to DOC. DOC was compared to 128 industry peers in the Diversified REITs industry. DOC has a medium profitability rating, but doesn't score so well on its financial health evaluation. While showing a medium growth rate, DOC is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
DOC had positive earnings in the past year.
DOC had a positive operating cash flow in the past year.
Each year in the past 5 years DOC has been profitable.
DOC had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a Return On Assets value of -0.20%, DOC is not doing good in the industry: 61.72% of the companies in the same industry are doing better.
DOC's Return On Equity of -0.51% is on the low side compared to the rest of the industry. DOC is outperformed by 61.72% of its industry peers.
DOC has a Return On Invested Capital (2.23%) which is in line with its industry peers.
The Average Return On Invested Capital over the past 3 years for DOC is in line with the industry average of 3.05%.
The 3 year average ROIC (2.19%) for DOC is below the current ROIC(2.23%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.2% | ||
| ROE | -0.51% | ||
| ROIC | 2.23% |
ROA(3y)2.1%
ROA(5y)2.44%
ROE(3y)5.05%
ROE(5y)5.78%
ROIC(3y)2.19%
ROIC(5y)1.92%
1.3 Margins
In the last couple of years the Profit Margin of DOC has grown nicely.
The Operating Margin of DOC (18.19%) is comparable to the rest of the industry.
DOC's Operating Margin has declined in the last couple of years.
DOC has a worse Gross Margin (60.08%) than 67.19% of its industry peers.
In the last couple of years the Gross Margin of DOC has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.19% | ||
| PM (TTM) | N/A | ||
| GM | 60.08% |
OM growth 3Y-2.63%
OM growth 5Y-7.45%
PM growth 3Y-30.28%
PM growth 5Y20.4%
GM growth 3Y0.52%
GM growth 5Y-2.11%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so DOC is destroying value.
The number of shares outstanding for DOC has been increased compared to 1 year ago.
Compared to 5 years ago, DOC has more shares outstanding
DOC has about the same debt/assets ratio as last year.
2.2 Solvency
DOC has an Altman-Z score of 0.30. This is a bad value and indicates that DOC is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of DOC (0.30) is worse than 61.72% of its industry peers.
The Debt to FCF ratio of DOC is 20.30, which is on the high side as it means it would take DOC, 20.30 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 20.30, DOC is in the better half of the industry, outperforming 76.56% of the companies in the same industry.
A Debt/Equity ratio of 1.20 is on the high side and indicates that DOC has dependencies on debt financing.
DOC has a Debt to Equity ratio of 1.20. This is comparable to the rest of the industry: DOC outperforms 54.69% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.2 | ||
| Debt/FCF | 20.3 | ||
| Altman-Z | 0.3 |
ROIC/WACC0.36
WACC6.29%
2.3 Liquidity
A Current Ratio of 0.11 indicates that DOC may have some problems paying its short term obligations.
DOC's Current ratio of 0.11 is on the low side compared to the rest of the industry. DOC is outperformed by 96.09% of its industry peers.
A Quick Ratio of 0.11 indicates that DOC may have some problems paying its short term obligations.
DOC has a Quick ratio of 0.11. This is amonst the worse of the industry: DOC underperforms 96.09% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.11 | ||
| Quick Ratio | 0.11 |
3. Growth
3.1 Past
The earnings per share for DOC have decreased strongly by -57.45% in the last year.
DOC shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 28.47% yearly.
DOC shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.58%.
DOC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.84% yearly.
EPS 1Y (TTM)-57.45%
EPS 3Y-16.9%
EPS 5Y28.47%
EPS Q2Q%-33.33%
Revenue 1Y (TTM)9.58%
Revenue growth 3Y12.51%
Revenue growth 5Y16.84%
Sales Q2Q%0.78%
3.2 Future
DOC is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -0.97% yearly.
DOC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.64% yearly.
EPS Next Y-34.04%
EPS Next 2Y-12.64%
EPS Next 3Y-7.02%
EPS Next 5Y-0.97%
Revenue Next Year3.67%
Revenue Next 2Y2.96%
Revenue Next 3Y3.48%
Revenue Next 5Y4.64%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 83.72, the valuation of DOC can be described as expensive.
The rest of the industry has a similar Price/Earnings ratio as DOC.
DOC's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.56.
The Price/Forward Earnings ratio is 62.70, which means the current valuation is very expensive for DOC.
DOC's Price/Forward Earnings is on the same level as the industry average.
DOC's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 23.79.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 83.73 | ||
| Fwd PE | 62.7 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, DOC is valued a bit cheaper than 65.63% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, DOC is valued a bit cheaper than 71.88% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 25.87 | ||
| EV/EBITDA | 13.03 |
4.3 Compensation for Growth
DOC's earnings are expected to decrease with -7.02% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)2.94
EPS Next 2Y-12.64%
EPS Next 3Y-7.02%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 7.31%, DOC is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 6.20, DOC pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 1.87, DOC pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.31% |
5.2 History
The dividend of DOC decreases each year by -2.76%.
DOC has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-2.76%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DOC has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DOC's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP-2176.08%
EPS Next 2Y-12.64%
EPS Next 3Y-7.02%
NYSE:DOC (12/15/2025, 11:04:06 AM)
16.745
+0.13 (+0.75%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners97.34%
Inst Owner Change5.77%
Ins Owners0.22%
Ins Owner Change0.78%
Market Cap11.64B
Revenue(TTM)2.80B
Net Income(TTM)-38.93M
Analysts77.5
Price Target20.94 (25.05%)
Short Float %2.86%
Short Ratio2.43
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.31% |
Yearly Dividend1.28
Dividend Growth(5Y)-2.76%
DP-2176.08%
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)9.17%
Min EPS beat(2)-19.41%
Max EPS beat(2)37.75%
EPS beat(4)2
Avg EPS beat(4)-12.11%
Min EPS beat(4)-79.16%
Max EPS beat(4)37.75%
EPS beat(8)5
Avg EPS beat(8)12.39%
EPS beat(12)7
Avg EPS beat(12)15.73%
EPS beat(16)10
Avg EPS beat(16)43.13%
Revenue beat(2)1
Avg Revenue beat(2)0.28%
Min Revenue beat(2)-0.37%
Max Revenue beat(2)0.94%
Revenue beat(4)3
Avg Revenue beat(4)0.74%
Min Revenue beat(4)-0.37%
Max Revenue beat(4)2.05%
Revenue beat(8)6
Avg Revenue beat(8)1.89%
Revenue beat(12)8
Avg Revenue beat(12)-4.75%
Revenue beat(16)11
Avg Revenue beat(16)-3.38%
PT rev (1m)-1.36%
PT rev (3m)-2.9%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2.08%
EPS NY rev (1m)2.15%
EPS NY rev (3m)-8.11%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.46%
Revenue NY rev (1m)0.18%
Revenue NY rev (3m)0.11%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 83.73 | ||
| Fwd PE | 62.7 | ||
| P/S | 4.15 | ||
| P/FCF | 25.87 | ||
| P/OCF | 9.38 | ||
| P/B | 1.53 | ||
| P/tB | 1.67 | ||
| EV/EBITDA | 13.03 |
EPS(TTM)0.2
EY1.19%
EPS(NY)0.27
Fwd EY1.6%
FCF(TTM)0.65
FCFY3.87%
OCF(TTM)1.79
OCFY10.66%
SpS4.03
BVpS10.93
TBVpS10.05
PEG (NY)N/A
PEG (5Y)2.94
Graham Number7.01
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.2% | ||
| ROE | -0.51% | ||
| ROCE | 2.83% | ||
| ROIC | 2.23% | ||
| ROICexc | 2.25% | ||
| ROICexgc | 2.46% | ||
| OM | 18.19% | ||
| PM (TTM) | N/A | ||
| GM | 60.08% | ||
| FCFM | 16.06% |
ROA(3y)2.1%
ROA(5y)2.44%
ROE(3y)5.05%
ROE(5y)5.78%
ROIC(3y)2.19%
ROIC(5y)1.92%
ROICexc(3y)2.2%
ROICexc(5y)1.94%
ROICexgc(3y)2.39%
ROICexgc(5y)2.1%
ROCE(3y)2.77%
ROCE(5y)2.44%
ROICexgc growth 3Y3.4%
ROICexgc growth 5Y2.94%
ROICexc growth 3Y2.73%
ROICexc growth 5Y2.33%
OM growth 3Y-2.63%
OM growth 5Y-7.45%
PM growth 3Y-30.28%
PM growth 5Y20.4%
GM growth 3Y0.52%
GM growth 5Y-2.11%
F-Score4
Asset Turnover0.14
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.2 | ||
| Debt/FCF | 20.3 | ||
| Debt/EBITDA | 5.78 | ||
| Cap/Depr | 73.87% | ||
| Cap/Sales | 28.24% | ||
| Interest Coverage | 1.93 | ||
| Cash Conversion | 78.53% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.11 | ||
| Quick Ratio | 0.11 | ||
| Altman-Z | 0.3 |
F-Score4
WACC6.29%
ROIC/WACC0.36
Cap/Depr(3y)101.04%
Cap/Depr(5y)178.11%
Cap/Sales(3y)35.69%
Cap/Sales(5y)67.36%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-57.45%
EPS 3Y-16.9%
EPS 5Y28.47%
EPS Q2Q%-33.33%
EPS Next Y-34.04%
EPS Next 2Y-12.64%
EPS Next 3Y-7.02%
EPS Next 5Y-0.97%
Revenue 1Y (TTM)9.58%
Revenue growth 3Y12.51%
Revenue growth 5Y16.84%
Sales Q2Q%0.78%
Revenue Next Year3.67%
Revenue Next 2Y2.96%
Revenue Next 3Y3.48%
Revenue Next 5Y4.64%
EBIT growth 1Y-12.91%
EBIT growth 3Y9.55%
EBIT growth 5Y8.14%
EBIT Next Year229.52%
EBIT Next 3Y52.42%
EBIT Next 5Y31.86%
FCF growth 1Y542.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y33.14%
OCF growth 3Y10.42%
OCF growth 5Y4.82%
HEALTHPEAK PROPERTIES INC / DOC FAQ
Can you provide the ChartMill fundamental rating for HEALTHPEAK PROPERTIES INC?
ChartMill assigns a fundamental rating of 3 / 10 to DOC.
Can you provide the valuation status for HEALTHPEAK PROPERTIES INC?
ChartMill assigns a valuation rating of 2 / 10 to HEALTHPEAK PROPERTIES INC (DOC). This can be considered as Overvalued.
What is the profitability of DOC stock?
HEALTHPEAK PROPERTIES INC (DOC) has a profitability rating of 4 / 10.
Can you provide the financial health for DOC stock?
The financial health rating of HEALTHPEAK PROPERTIES INC (DOC) is 1 / 10.
Can you provide the dividend sustainability for DOC stock?
The dividend rating of HEALTHPEAK PROPERTIES INC (DOC) is 5 / 10 and the dividend payout ratio is -2176.08%.